Results 51 to 60 of about 126,328 (301)
Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions. [PDF]
PLoS ONE, 2012 The objective of the present study was to investigate the presence of interleukin (IL)-27 in pleural effusions and to evaluate the diagnostic significance of pleural IL-27.
Wei-Bing Yang +9 more
doaj +1 more source
Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis [PDF]
, 2012 Rationale: Talc is very effective for pleurodesis, but there is concern about complications, especially acute respiratory distress syndrome. Objectives: It was the aim of this study to investigate if talc with a high concentration of small particles ...
Arellano Orden, Elena +5 more
core +1 more source
Malignant pleural effusion: from bench to bedside
European Respiratory Review, 2016 Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ...
I. Psallidas +4 more
semanticscholar +1 more source
Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.
Annals of the American Thoracic Society, 2019 Advanced malignancy is a prevalent cause of exudative pleural effusion. The management of malignant pleural effusion (MPE) has been the subject of several recent randomized controlled trials and excellent reviews.
V. Kaul +3 more
semanticscholar +1 more source
Diagnostic value of procalcitonin in pleural effusion
Egyptian Journal of Chest Disease and Tuberculosis, 2020 Background A wide range of diseases can cause pleural effusion. Its diagnosis and management remain a clinical challenge, bearing a significant cost to both patients and health care system.
Abdelsadek H Al-Aarag +3 more
doaj +1 more source
Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project [PDF]
, 2017 Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection ...
Bintcliffe, Oliver +10 more
core +1 more source
Management of malignant pleural effusions
Current Opinion in Pulmonary Medicine, 2020 Purpose of review Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options.
Dipper, Alexandra +2 more
openaire +6 more sources
Therapeutic Advances in Medical Oncology, 2019 Background: Tumour markers in pleural fluid and their diagnostic value are subject to debate. Although there are several studies on this topic, standardized cut-off values do not exist.
K. Hackner, P. Errhalt, S. Handzhiev
semanticscholar +1 more source
Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
The Egyptian Journal of Bronchology, 2019 Background Pleural effusion can arise as a result of more than 50 recognized causes and the differentiation between benign and malignant origin of the fluid is still a diagnostic challenge.
Omar M. Mohammed +5 more
doaj +1 more source
Emergency Medicine International, 2022 Objective. The aim of the study is to investigate the clinical value of matrix metalloproteinases-3 (MMP-3) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) combined with adenosine deaminase (ADA) in pleural effusion and serum in benign and malignant
Zhiyang Xu +4 more
doaj +1 more source